Karkus Ted William has filed 13 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 500000 shares of ProPhase Labs, Inc. ($PRPH) on September 09, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 9, 2025 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | A | warrants | 500000 | $0.00 | 500,000.0000 | 41,879,017 | 9999.99% | 1.19% |
| March 17, 2024 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | A | Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| March 17, 2024 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | A | Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 50.00% | 0.00% |
| April 5, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | G | Common Stock, par value $0.005 | 50000 | $0.00 | 3,583,750.0000 | 0 | 1.41% | 0.00% |
| April 5, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | G | Common Stock, par value $0.005 | 50000 | $0.00 | 3,583,750.0000 | 0 | 1.38% | 0.00% |
| April 3, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | A | Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | G | Common Stock, par value $0.005 | 100000 | $0.00 | 3,583,750.0000 | 0 | 2.71% | 0.00% |
| Feb. 1, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | F | Common Stock, par value $0.005 | 268337 | $8.18 | 3,683,750.0000 | 0 | 6.79% | 0.00% |
| Feb. 1, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | M | Option (right to buy) | 500000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 1, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | M | Common Stock, par value $0.005 | 500000 | $0.60 | 3,952,087.0000 | 0 | 14.48% | 0.00% |
| Jan. 13, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | M | Common Stock, par value $0.005 | 600000 | $0.60 | 3,771,318.0000 | 0 | 18.92% | 0.00% |
| Jan. 13, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | F | Common Stock, par value $0.005 | 319231 | $9.36 | 3,452,087.0000 | 0 | 8.46% | 0.00% |
| Jan. 13, 2023 | ProPhase Labs, Inc. | $PRPH | Karkus Ted William | CEO & CHAIRMAN | M | Option (right to buy) | 600000 | $0.00 | 500,000.0000 | 0 | 54.55% | 0.00% |